follicular B-cell non-Hodgkin lymphoma

Gamida doses first subject in Phase I/II cell therapy trial for lymphomas
Clinical Trials Arena
Thu, 08/11/22 - 12:17 pm
Gamida Cell
natural killer cell therapy
GDA-201
diffuse large B-cell lymphoma
follicular B-cell non-Hodgkin lymphoma
Failing to confirm clinical benefit, Gilead pulls 2 accelerated approval indications for cancer drug
Endpoints
Fri, 01/21/22 - 11:07 am
Gilead Sciences
Zydelig
follicular B-cell non-Hodgkin lymphoma
small lymphocytic leukemia